Farallon Capital Partners, L.P. 13D and 13G filings for Crinetics Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-05 2:45 pm Purchase | 2025-12-31 | 13G | CRINETICS PHARMACEUTICALS INC CRNX | Farallon Capital Partners, L.P. | 8,024,098 8.500% | 2,399,000 (+42.65%) | Filing |
| 2025-09-08 5:36 pm Purchase | 2025-08-29 | 13G | CRINETICS PHARMACEUTICALS INC CRNX | Farallon Capital Partners, L.P. | 5,625,098 6.000% | 5,625,098 (New Position) | Filing |